SUMMARY We investigated the effect of indomethacin, a widely used nonsteroidal antiinflammatory drug, on the healing of myocardial infarction (MI). Experimental MI was produced in anesthetized, openchest dogs by occluding the left anterior descending coronary artery. Ten dogs received indomethacin, 10 mg/kg i.v., and 11 received saline, 15 minutes and 3 hours after occlusion. After 6 weeks, the dogs were killed and their hearts were subjected to morphologic and biochemical analysis. The After lidocaine, 1.5 mg/kg i. v., was administered, the left anterior descending coronary artery was permanently occluded with a silk ligature. A second, similar dose of lidocaine was administered 5 minutes after occlusion in all dogs. The first seven dogs served as controls and received saline. (These dogs also served as controls in another study. 8) The rest of the dogs were randomized by drawing lots into two groups, six saline and 13 indomethacin, and the investigators were blinded as to which agent the dog received until all scar measurements had been completed. The control dogs received 50 ml of saline infused over 5 minutes. The other 13 dogs received indomethacin (Sigma Chemical Company) (10 mg/kg i.v.) in 50 ml of normal saline infused over 5 minutes, at 15 minutes and 3 hours after occlusion (total dose of 20 mg/kg). This dose of indomethacin was used because it was similar to that used by other investigators to ensure complete inhibition of prostaglandin synthesis in the cardiac vascular bed.9' '°All agents were infused through a peripheral vein. The chest was closed, the air was evacuated from the thoracic cavity and the dogs were returned to the kennel. One dose of benzanthine penicillin, 1.2 million units, was given intramuscularly to each dog.
SUMMARY We investigated the effect of indomethacin, a widely used nonsteroidal antiinflammatory drug, on the healing of myocardial infarction (MI). Experimental MI was produced in anesthetized, openchest dogs by occluding the left anterior descending coronary artery. Ten dogs received indomethacin, 10 mg/kg i.v., and 11 received saline, 15 minutes and 3 hours after occlusion. After 6 weeks, the dogs were killed and their hearts were subjected to morphologic and biochemical analysis. The average thickness of the transmural scar and the noninfarcted left ventricular wall was measured at multiple sites in formalinfixed left ventricular slices and the ratio of the thickness of the transmural scar to the noninfarcted wall determined. The average thickness of the noninfarcted wall was 8 ALTHOUGH interventions designed to reduce myocardial infarction size have been studied,' 2 relatively little is known about the effects of drugs on the formation of the myocardial scar after myocardial infarction. The healing phase has been viewed as a process that follows a temporally predictable morphologic course.3 4 That this may not be true was demonstrated when glucocorticosteroids were shown to retard the rate of myocardial infarction healing,5 cause scar thinning after experimental infarction6 and possibly lead to formation of myocardial aneurysms in humans. 7 Ibuprofen, a nonsteroidal, antiinflammatory compound, has been shown to cause scar thinning when administered after experimental myocardial infarction, while aspirin does not. 8 We investigated the effects of indomethacin, which has a potent inhibitory effect on prostaglandin synthesis, on scar formation after myocardial necrosis.
Methods Experimental Preparation
Mongrel dogs of either sex that weighed [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] After lidocaine, 1.5 mg/kg i. v., was administered, the left anterior descending coronary artery was permanently occluded with a silk ligature. A second, similar dose of lidocaine was administered 5 minutes after occlusion in all dogs. The first seven dogs served as controls and received saline. (These dogs also served as controls in another study. 8) The rest of the dogs were randomized by drawing lots into two groups, six saline and 13 indomethacin, and the investigators were blinded as to which agent the dog received until all scar measurements had been completed. The control dogs received 50 ml of saline infused over 5 minutes. The other 13 dogs received indomethacin (Sigma Chemical Company) (10 mg/kg i.v.) in 50 ml of normal saline infused over 5 minutes, at 15 minutes and 3 hours after occlusion (total dose of 20 mg/kg). This dose of indomethacin was used because it was similar to that used by other investigators to ensure complete inhibition of prostaglandin synthesis in the cardiac vascular bed.9' '°All agents were infused through a peripheral vein. The chest was closed, the air was evacuated from the thoracic cavity and the dogs were returned to the kennel. One dose of benzanthine penicillin, 1.2 million units, was given intramuscularly to each dog.
After 6 weeks, the dogs were reanesthetized with pentobarbital, 30 mg/kg i.v., killed with an overdose 1290 of potassium chloride and the hearts were excised. Potassium chloride injection allowed all hearts to be arrested in diastole.
Assessment of Wall Thickness and Expansion
The left ventricle was dissected free from the right ventricular free wall and structures above the atrioventricular rings, loosely packed with. gauze to prevent collapse of the left ventricular cavity, and allowed to fix in 10% neutral buffered formalin for 3 days. After fixation, the heart was sectioned from base to apex into 3-5-mm transverse sections parallel to the atrioventricular groove. Wall and scar thickness were measured on each section along radii that passed through the center of the ventricular cavity ( fig. 1) . The thicknesses of the normal wall and the scar in each slice were measured in three to five widely separated locations and the values for each set of measurements were averaged. To take into account variability in dog size, a ratio was determined of average scar thickness to average noninfarcted wall thickness in each slice. An average ratio in each dog was determined by averaging the ratios in each slice containing infarcted tissue. Measurements were performed in a blinded fashion.
Infarct size was assessed after 6 weeks by area planimetry and was expressed as a percentage of the left ventricle.
For quantification of the degree of expansion, an index was determined for each heart as previously described." The midpoint of the ventricular septum was identified by linear measurement and the perpendicular bisector of the left ventricular free wall was marked. Intersections of the septal bisector of the free wall divided each section into an anterior and posterior segment. The transverse section that contained the greatest percentage of infarcted tissue was selected for each heart, and the lengths of the endocardial margins for the anterior infarct segment and for the noninfarcted posterior segment were measured. An index of expansion was determined by dividing the length of the infarcted segment by the endocardial length of the noninfarcted segment. Expansion was considered if the expansion index was more than 1.09.11
Analysis of Hydroxyproline Content
Tissue samples of 100-200 mg were obtained from the endocardial and epicardial myocardium of normal and infarcted areas, oven-dried to a constant weight and acid-hydrolyzed in 6N HCI at 1 10°C for 12 hours. After neutralization and decolorization of the hydrolysate, hydroxyproline concentration was assayed by the method of Newman and Logan.'2
Histologic Analysis
Representative formalin-fixed, transmural, transverse sections of noninfarcted and infarcted myocardium were conventionally processed and embedded in paraffin. Two to three such sections stained with hematoxylin-eosin and Masson' s trichrome were examined from each heart. Histologic features of necrosis and healing were assessed and graded from 0 (not present) to 4 (most prominent), as previously described,3' 4 for necrosis, leukocytes, macrophages, neutrophils, vascular proliferation, fibroblasts and collagen. The histologic score for each feature for each dog was averaged over the several slices examined.
Statistical Analysis
Unpaired t tests were used to calculate the significance of differences of the wall thickness measurements, ratio of scar to noninfarcted wall thickness, infarct size and hydroxyproline content between the groups. Values listed in the text are the mean ± SEM.
Results
Twenty-six dogs entered the protocol. Three dogs developed ventricular fibrillation and died within 30 minutes of coronary occlusion. One dog died suddenly 3 days after coronary occlusion. One dog had subendocardial infarction at the time of examination. These five dogs were excluded from the study. Of the 21 dogs that survived for 6 weeks, 10 were in the indomethacin-treated group and 11 were in the control group 2). The ratio of scar thickness to noninfarcted wall thickness was significantly higher in the control dogs, 0.83 + 0.07, than that in the indomethacin-treated group, 0.43 + 0.04 (p < 0.001). All but two hearts in the control group had a ratio exceeding 0.60; all but one heart in the treated group had a ratio of less than cle was similar in both groups at the end of 6 weeks (15.28 ± 1.13% in the control and 12.60 ± 1.48% in the indomethacin group; NS).
The expansion index was 1.02 ± 0.03 in the control group and was significantly higher in the indomethacin group, 1.15 ± 0.03 (p < 0.005). All but two dogs in the control group had an expansion index smaller than 1.09; all but two in the indomethacin group had an expansion index exceeding 1.09. droxyproline concentration range of 3.5-4.4 gg/mg dry weight in both control and treated groups. Larger quantities of collagen were contained within the epicardial and endocardial portions of the scar, 13.8-29.8 rg/mg. The hydroxyproline concentrations tended to be lower, but not significantly, in the scar tissue of the indomethacin-treated group. Thus, treatment with indomethacin did not affect the hydroxyproline concentration in the scar tissue or in the noninfarcted myocardium (table 1) .
Histologic Analysis
The qualitative histologic appearances of the infarcted region were similar in the control and indomethacin-treated dogs. There was sharp demarcation between the evolving scar and normal myocardium. Islands of necrotic muscle and polymorphonuclear leukocytes were rare. Collagen was a prominent feature of these healing infarcts. There were prominent, thickwalled blood vessels and numerous fibroblasts and mononuclear inflammatory cells, some of which were pigmented. In most cases, the evolving scar was relatively homogeneous and essentially had the appearance of human 6-week-old myocardial infarcts. The similarity in the treated and control groups using the 
Discussion
This study demonstrates marked thinning of myocardial scars 6 weeks after coronary ligation in dogs treated with indomethacin 15 minutes and 3 hours after coronary occlusion. In the treated group, nine of 10 dogs had evidence of severe scar thinning, defined as a ratio of the thickness of the scar to that of the noninfarcted wall of 0.60 or less; in contrast, in the control group, only two dogs had a scar thinning ratio of less than 0.60. Hydroxyproline concentration, which reflects the collagen content, and the histologic examination of the scars did not differ between control and the indomethacin-treated dogs. Thus, although the scars were thinner in the indomethacin group, the tissue was qualitatively similar in both groups. Indomethacin may have caused myocardial thinning or expansion early in the postinfarction course, which was followed by normal healing and collagen deposition on a thinned infarct. The larger expansion index in the indomethacin-treated dogs suggests that this might be the mechanism. In dogs, the infarct healing process is complete within 6 weeks. In smaller animals, such as rats, scar formation is complete by 3 weeks. We chose the dog model because it more closely resembles the time course of infarct healing in man.
In a recent study from our laboratory, ibuprofen, but not aspirin, administered after myocardial infarction resulted in post-myocardial infarct scar thinning.8 Indomethacin is a potent inhibitor of prostaglandin synthesis. 14. 15 Indomethacin inhibits cyclooxygenase activity and thereby diminishes generation of cyclic endoperoxides from arachidonic acid, blocking the ensuing cascade of prostaglandins and nonprostaglandin products. 15 This accounts for the reduction in vasodilation and edema in inflammatory sites. '5' 16 In a model using carrageenin-induced inflammation in the rat, indomethacin in doses of 0.5-1.0 mg/kg reduced prostaglandin concentration by more than 90% from the control values and increased total leukocytes by approximately 65%. At doses greater than 2.0 mg/kg, however, leukocyte migration was reduced in a dose-dependent manner, while prostaglandin synthesis remained inhibited. '6 The fact that indomethacin and other aspirin-like drugs have variable effects on leukocyte accumulation in inflammation and that inhibition of leukocyte migration is not correlated with cyclooxygenase activity suggests that additional mediators may play a role in inflammatory cell infiltration.'6 The fatty acid precursors of the prostaglandins can be oxygenated by a lipoxygenase, which converts arachidonic acid to a hydroxy acid, 12-L hydroxyeicosatetraenoic acid (HETE). HETE is a potent chemotactic agent for polymorphonuclear leukocytes. Indomethacin and other aspirinlike drugs generally do not prevent the generation of HETE from arachidonic acid and may, in some cases, increase lipoxygenase products at low doses. This may explain their failure to prevent the accumulation of leukocytes in inflammation. 7 ' 1 18 Antiinflammatory corticosteroids reduce prostaglandin concentrations by mechanisms other than cyclooxygenase inhibition. 17 Corticosteroids also prevent the release of fatty acids from phospholipids, resulting in a reduction of both cyclooxygenase and lipoxygenase products. Thus, if HETE is an important mediator of chemotaxis in vivo, a reduction of lipoxygenase products by antiinflammatory steroids may explain why steroids strongly suppress cell migration. This dual inhibition of both arachidonate cyclooxygenase (prostaglandin synthetase) and lipoxygenase may explain the more potent antiinflammatory activity of the steroids relative to indomethacin and other aspirin-like drugs. Perhaps the reduced leukocyte migration observed at high doses of the nonsteroidal antiinflammatory agents is due to dual inhibition of cyclooxygenase and lipoxygenase. 16, 19 Whether the relationship of these metabolic pathways and their differential inhibition by glucocorticosteroids, indomethacin, ibuprofen and aspirin are responsible for their different effects on scar formation after myocardial infarction is not known.
Indomethacin, in addition to its antiinflammatory activity, may inhibit collagen synthesis in some situations. For example, it reduces collagen concentration in granulation tissue induced by cotton pellets20 and inhibits experimental pulmonary fibrosis induced by bleomycin in rats.21 However, in our study, neither the histologic appearance nor collagen concentrations differed between hearts of indomethacin-treated and control dogs, so it is unlikely that inhibition of collagen synthesis by indomethacin is responsible for the scar thinning demonstrated in this study.
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